Acute fibrinous and organizing pneumonia after lung transplantation: A case report of treatment with infliximab and tocilizumab and literature review
Introduction: Acute fibrinous and organizing pneumonia (AFOP) is a severe form of acute lung injury which can occur after lung transplantation. Treatment is empiric, based on immunosuppressive regimens and the mortality rate is very high. Case presentation: We report the case of a young lung transpl...
Saved in:
Main Authors: | Christophe Abellan, Foteini Ioakeim, Alessio Casutt, Benoit Lechartier, Zisis Balmpouzis, Samuel Rotman, Leslie Noirez, Isabelle Rochat, John-David Aubert, Angela Koutsokera |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2025-01-01
|
Series: | Respiratory Medicine Case Reports |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2213007124001825 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Real-Life Use of Tocilizumab in the Treatment of Severe COVID-19 Pneumonia
by: Ruth Alex, et al.
Published: (2022-01-01) -
Tocilizumab Use in a Chronic Hemodialysis Patient for the Management of COVID-19-Associated Pneumonia and Acute Respiratory Distress Syndrome
by: Sudeendra Gupta, et al.
Published: (2020-01-01) -
Long Term Safety of Infliximab
by: Thomas F Schaible
Published: (2000-01-01) -
Response of Fibroblastic Rheumatism to Infliximab
by: Ricardo Romiti, et al.
Published: (2009-01-01) -
Tocilizumab, an Exploratory Treatment for Severe COVID-19 Patients
by: Yong Wang, et al.
Published: (2022-01-01)